LOL!
So many lies in this thread by GWB that it’s hard to spin them together.
Vaccine Linked to Myocarditis... you fucking Dangerous idiots GWB and friends
- Thread starter jem
- Start date
So many lies in this thread by GWB that it’s hard to spin them together.
No such thing as Long Covid. Come see me in five years with people still suffering from Covid symptoms that they have today, then you can claim such a thing as long Covid. As of today the vaccine risk is far greater for healthy young people than the risks associated with Covid.
A. You presented a fucking model you moron.... you need to present evidence.
studies which did contact tracing and found significant asymptomatic spread.
you have been lying your ass off outdoor spread and asymptomatic spread for a year.
here is the language from you citation...
Findings In this decision analytical model assessing multiple scenarios for the infectious period and the proportion of transmission from individuals who never have COVID-19 symptoms, transmission from asymptomatic individuals was estimated to account for more than half of all transmission.
Meaning The findings of this study suggest that the identification and isolation of persons with symptomatic COVID-19 alone will not control the ongoing spread of SARS-CoV-2.
b.
studies which did contact tracing and found significant asymptomatic spread.
you have been lying your ass off outdoor spread and asymptomatic spread for a year.
here is the language from you citation...
Findings In this decision analytical model assessing multiple scenarios for the infectious period and the proportion of transmission from individuals who never have COVID-19 symptoms, transmission from asymptomatic individuals was estimated to account for more than half of all transmission.
Meaning The findings of this study suggest that the identification and isolation of persons with symptomatic COVID-19 alone will not control the ongoing spread of SARS-CoV-2.
b.
Here are the Results of the study. Read them and educate yourself.
Results The baseline assumptions for the model were that peak infectiousness occurred at the median of symptom onset and that 30% of individuals with infection never develop symptoms and are 75% as infectious as those who do develop symptoms. Combined, these baseline assumptions imply that persons with infection who never develop symptoms may account for approximately 24% of all transmission. In this base case, 59% of all transmission came from asymptomatic transmission, comprising 35% from presymptomatic individuals and 24% from individuals who never develop symptoms. Under a broad range of values for each of these assumptions, at least 50% of new SARS-CoV-2 infections was estimated to have originated from exposure to individuals with infection but without symptoms.
===============
There are plenty of other studies show asymptomatic spread of COVID.... there should not be a need to pull up dozens of studies show asymptomatic spread of COVID (which you will just deny anyway) to demonstrate the obvious --- that there is plenty of asymptomatic spread of COVID.
There is an entire thread dedicated to Long COVID.
https://www.elitetrader.com/et/threads/long-covid-a-significant-public-health-threat.356371/
Read it and learn something.
this is the article cited in the article you posted... you moronic lying piece of shit... I have told you this could be the case since that La Jolla study... months ago about t cell immunity boding well for vaccines.
you do not eve understand have vaccines work do you?
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00025-2/fulltext
In any viral infection, it is expected that both antibody and T-cell responses will play roles in protective immunity and there are published studies to suggest that this might also be true for SARS-CoV-2 infection.
In patients who have recovered from COVID-19, some individuals have very low levels or absence of neutralising antibodies, indicating that T-cell immunity could be the dominant mechanism, at least in some individuals.
However, high levels of neutralising antibodies appear to be correlated with protection against reinfection.
you do not eve understand have vaccines work do you?
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00025-2/fulltext
In any viral infection, it is expected that both antibody and T-cell responses will play roles in protective immunity and there are published studies to suggest that this might also be true for SARS-CoV-2 infection.
In patients who have recovered from COVID-19, some individuals have very low levels or absence of neutralising antibodies, indicating that T-cell immunity could be the dominant mechanism, at least in some individuals.
However, high levels of neutralising antibodies appear to be correlated with protection against reinfection.
So you are citing a paper that is merely referenced. And only taking a few sentences from it out of context.
A paper named Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study --- that goes on to describe a study showing how Antibodies provide immunity.
LOL.
Are you stupid or merely a troll?
read this you lying dumb moron... and now tell me there is no such thing as t cell immunity. you have no understanding of science, data or stats.
Researchers in the United States have shown that the Pfizer/BioNTech and Moderna messenger RNA (mRNA) vaccines are effective at generating T-cell immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).May 5, 2021
Pfizer/BioNTech and Moderna vaccines induce T-cell ...
Researchers in the United States have shown that the Pfizer/BioNTech and Moderna messenger RNA (mRNA) vaccines are effective at generating T-cell immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
The team found that vaccinated individuals developed robust T-cell responses to the SARS-CoV-2 spike protein that the virus uses to bind to and infect host cells.
The researchers – from Massachusetts General Hospital and Harvard Medical School in Boston – report that the T-cell response increased significantly from baseline after just one vaccine dose. After a second dose, the response was more potent than in a convalescent cohort.
However, Marcela Maus and colleagues also found that vaccinated individuals had diminished T-cell responses against the SARS-CoV-2 variants that emerged in the U.K. (B.1.1.7), South Africa (B.1.351), and Brazil (P1).
The team says it will be important to determine how T-cell immunity impacts the aggregate immune response to the variants and whether a reduced T-cell response translates to adverse clinical outcomes.
Researchers in the United States have shown that the Pfizer/BioNTech and Moderna messenger RNA (mRNA) vaccines are effective at generating T-cell immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).May 5, 2021
Pfizer/BioNTech and Moderna vaccines induce T-cell ...
Researchers in the United States have shown that the Pfizer/BioNTech and Moderna messenger RNA (mRNA) vaccines are effective at generating T-cell immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
The team found that vaccinated individuals developed robust T-cell responses to the SARS-CoV-2 spike protein that the virus uses to bind to and infect host cells.
The researchers – from Massachusetts General Hospital and Harvard Medical School in Boston – report that the T-cell response increased significantly from baseline after just one vaccine dose. After a second dose, the response was more potent than in a convalescent cohort.
However, Marcela Maus and colleagues also found that vaccinated individuals had diminished T-cell responses against the SARS-CoV-2 variants that emerged in the U.K. (B.1.1.7), South Africa (B.1.351), and Brazil (P1).
The team says it will be important to determine how T-cell immunity impacts the aggregate immune response to the variants and whether a reduced T-cell response translates to adverse clinical outcomes.
